PSYB.H — Psybio Therapeutics Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for Psybio Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 June 30th | 2019 June 30th | 2020 June 30th | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | fx Final | fx Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.206 | 0.193 | 0.162 | 3.81 | 0.001 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.206 | 0.193 | 0.162 | 4 | 0.253 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | — | — | — | 0.127 |
Other Long Term Assets | |||||
Total Assets | 0.206 | 0.193 | 0.162 | 4.01 | 0.39 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.036 | 0.043 | 0.034 | 1.04 | 1.98 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.036 | 0.043 | 0.034 | 1.29 | 1.98 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 0.17 | 0.15 | 0.128 | 2.72 | -1.59 |
Total Liabilities & Shareholders' Equity | 0.206 | 0.193 | 0.162 | 4.01 | 0.39 |
Total Common Shares Outstanding |